Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00579085

Organisation Name: Drexel University

Overal Status: Completed

Start Date: September 2006

Last Update: June 17, 2010

Lead Sponsor: Drexel University College of Medicine

Brief Summary: Complex Regional Pain Syndrome is a debilitating and extremely difficult to treat condition. There is a large body of evidence demonstrating the therapeutic value of N-methyl-D-aspartate (NMDA)-receptor antagonists in CRPS. The NMDA antagonist ketamine has been shown to be effective in the treatment of CRPS, resulting in complete remission of the disease in some patients. The purpose of this study is to evaluate intravenous outpatient infusion of sub-anesthetic doses of ketamine for the treatment of CRPS. A thorough evaluation of this procedure, providing information into the degree of relief and which of the constellation of RSD symptoms are best alleviated by this procedure would result in the optimization of this therapy for the treatment of CRPS.

Conditions:
  • Complex Regional Pain Syndrome


Total execution time in seconds: 0.23447608947754